Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Serum 1,25(OH)2D concentrations were comparable among the experimental groups (Figure 2D), whereas Gna11+/: and Gna11: /: mice displayed significantly reduced serum phosphate levels (Figure 2E).

Source: Gna11 ablation in mice phenocopies FHH and reveals elevated FGF23 levels.. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia

Study design awaiting verification · JCI Insight · 2024

Original publication title

Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia

Birol Ay; Sajin Marcus Cyr; Kaitlin Klovdahl; Wen Zhou; Christina M. Tognoni; Yorihiro Iwasaki; Eugene P Rhee; Alpaslan Dedeoglu; Petra Simic; Murat Bastepe

© 2024 Ay et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Fibroblast growth factor 23 (FGF23) production has recently been shown to increase downstream of Gαq/11-PKC signaling in osteocytes. Inactivating mutations in the gene encoding Gα11 (GNA11) cause familial hypocalciuric hypercalcemia (FHH) due to impaired calcium-sensing receptor signaling. We explored the effect of Gα11 deficiency on FGF23 production in mice with heterozygous (Gna11+/: ) or homozygous (Gna11: /: ) ablation of Gna11. Both Gna11+/: and Gna11: /: mice demonstrated hypercalcemia and mildly raised parathyroid hormone levels, consistent with FHH.

Strikingly, these mice also displayed increased serum levels of total and intact FGF23 and hypophosphatemia. Gna11: /: mice showed augmented Fgf23 mRNA levels in the liver and heart, but not in bone or bone marrow, and also showed evidence of systemic inflammation with elevated serum IL-1β levels. Furin gene expression was significantly increased in the Gna11: /: liver, suggesting enhanced FGF23 cleavage despite the observed rise in circulating intact FGF23 levels. Gna11: /: mice had normal renal function and reduced serum levels of glycerol-3-phosphate, excluding kidney injury as the primary cause of elevated intact FGF23 levels.

Thus, Gα11 ablation caused systemic inflammation and excess serum FGF23 in mice, suggesting that patients with FHH: at least those with GNA11 mutations: may be at risk for these complications.

Authors’ abstract

Fibroblast growth factor 23 (FGF23) production has recently been shown to increase downstream of Gαq/11-PKC signaling in osteocytes. Inactivating mutations in the gene encoding Gα11 (GNA11) cause familial hypocalciuric hypercalcemia (FHH) due to impaired calcium-sensing receptor signaling. We explored the effect of Gα11 deficiency on FGF23 production in mice with heterozygous (Gna11+/: ) or homozygous (Gna11: /: ) ablation of Gna11. Both Gna11+/: and Gna11: /: mice demonstrated hypercalcemia and mildly raised parathyroid hormone levels, consistent with FHH.

Strikingly, these mice also displayed increased serum levels of total and intact FGF23 and hypophosphatemia. Gna11: /: mice showed augmented Fgf23 mRNA levels in the liver and heart, but not in bone or bone marrow, and also showed evidence of systemic inflammation with elevated serum IL-1β levels. Furin gene expression was significantly increased in the Gna11: /: liver, suggesting enhanced FGF23 cleavage despite the observed rise in circulating intact FGF23 levels. Gna11: /: mice had normal renal function and reduced serum levels of glycerol-3-phosphate, excluding kidney injury as the primary cause of elevated intact FGF23 levels.

Thus, Gα11 ablation caused systemic inflammation and excess serum FGF23 in mice, suggesting that patients with FHH: at least those with GNA11 mutations: may be at risk for these complications.

Publication and source details

Original title: Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia

Birol Ay; Sajin Marcus Cyr; Kaitlin Klovdahl; Wen Zhou; Christina M. Tognoni; Yorihiro Iwasaki; Eugene P Rhee; Alpaslan Dedeoglu; Petra Simic; Murat Bastepe

JCI Insight · 2024

Address correspondence to: Murat Bastepe, Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St., Boston, Massachusetts 02114, USA, Phone: 617.726.3269; Email: mbastepe@mgh.harvard.edu.© 2024 Ay et al.2024Ay et al.https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.National Institutes of HealthR01DK121776 National Institutes of Healthhttps://doi.org/10.13039/100000002 P30 AR075042This is a Core grant given to investigators in our Unit none of whom are actually authors on this ms. However, since we used the Core services, we are asked to acknowledge the grant.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T12:31:48.797655+00:00

DOI: 10.1172/jci.insight.178993 · PMC11141917